ACM
CASI

ADAR1 Capital Management’s CASI Pharmaceuticals CASI Stock Holding History

ADAR1 Capital Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-44,120
Closed -$52.1K – 228
2025
Q2 		$52.1K Sell
44,120
-3,300
-7% -$6.05K 0.01% 190
2025
Q1 		$102K Buy
47,420
+1,100
+2% +$2.69K 0.02% 165
2024
Q4 		$131K Sell
46,320
-18,515
-29% -$87.8K 0.03% 172
2024
Q3 		$399K Buy
64,835
+56,595
+687% +$366K 0.07% 127
2024
Q2 		$45.3K Buy
+8,240
New +$25.6K 0.01% 191

Other funds holding CASI

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return